Wall Street PR

Steve Hackney

Cepheid Breaks Losing Streak, Gains 4% (CPHD)

Today, molecular diagnostics company Cepheid (NASDAQ: CPHD), which was on a decline after reporting a fiscal 2012 third-quarter loss and a lowered annual revenue and

Cepheid Breaks Losing Streak, Gains 4% (CPHD)

Today, molecular diagnostics company Cepheid (NASDAQ: CPHD), which was on a decline after reporting a fiscal 2012 third-quarter loss and a lowered annual revenue and